Abstract P5-15-09: A LINE Bot mobile app module to augment long-term and real-time follow-up of patients with breast cancer

Abstract

Abstract Purpose: Female breast cancer is one of the most frequent cancer types in Taiwan, and several novel therapeutic options have been introduced in recent years. Patients usually received a combination of treatment modalities based on the pathological type, cancer staging and personal preferences. Due to the complexity of treatment involved, specifically associated adverse reactions and variable treatment duration, assessment of quality of life (QoL), long-term and real-time surveillance are difficult to achieve. To overcome the above limitations, we developed a LINE Bot module to augment the follow-up of patients with breast cancer. Materials and Methods: The LINE Bot is comprised of personal information including disease characteristics, therapeutic timeframe, a quality-of-life measuring instrument, the EORTC QLQ-C30 and QLQ-BR23, knowledge and guidance concerning breast cancer. The mobile app also serves as a platform for the patients to interact with their conducting physicians. Results: During the nine-month enrollment period, 108 patients who had received breast cancer therapies at our institute were identified on hospitalization or outpatient basis. Invitation was made in person, and an access to the mobile app or a direct link to online quality-of-life questionnaire was provided. Patients with ECOG=0 reported better global health/Global quality of life status (62 versus 14, P<0.01), physical function (90 versus 73, P<0.05), cognitive function (81 versus 28, P<0.01), less pain (24 versus 67, P<0.01) and dyspnea (10 versus 67, P<0.01) compared to those with ECOG>1. Patients in the status of follow-up had better role function than those undergoing active treatment (92 versus 78, P<0.05). Conclusion: The establishment of the LINE Bot module could improve outcomes assessment for patients themselves and physicians in charge. It provided an opportunity to reflect quality-of-life influenced by each treatment modality and disease status as these patients could repeat the questionnaire at any timing. The platform for interaction could also contribute to enhancing the quality of care. Citation Format: Pei-Ju Lien, Chi-Cheng Huang, Ling-Ming Tseng. A LINE Bot mobile app module to augment long-term and real-time follow-up of patients with breast cancer [abstract]. In: Proceedings of the 2021 San Antonio Breast Cancer Symposium; 2021 Dec 7-10; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2022;82(4 Suppl):Abstract nr P5-15-09.